Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Antibiotics
- Balanced Salt Solutions
- Cell Dissociation Reagents
- Cell Freezing Media
- Cell Health Assays
- Cell Identification Service
- Cell Lines
- Complete Growth Media
- Cytokines
- Exosome Isolation Kits
- Growth Supplements
- Induced Differentiation Media
- Liquid Basal Media
- Other Reagents
- Powder Basal Media
- Primary Cell Isolation and Culture Kit
- Primary Cells
- Removal Media
- Removal Reagents
- Serum
- Serum-Free Media
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Kyrgyzstan
- Luxembourg
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 32,193 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Prostate cancer associated 3 (PCA3) is a potential indicator of the pathological grades of prostate cancer (2026-02-17)
Journal: Discover Oncology (2026) IF: 2.9Products Cited: RPMI-1640 Medium, Fetal Bovine Serum -
Identification of the disulfidptosis-related gene G6PD as a potential biomarker and therapeutic target in pancreatic ductal adenocarcinoma by integrative bioinformatics analysis and experimental validation (2026-03-04)
Journal: Discover Oncology (2026) IF: 2.9Products Cited: HPDE-7 Cells Line -
Integrated analysis of Morusin inhibiting esophageal cancer via network pharmacology molecular dynamics simulation and in vitro validation (2026-03-23)
Journal: Discover Oncology (2026) IF: 2.9Products Cited: Het-1A Cells Line -
Identification of mitochondrial oxidative stress-related genes for estimating prognosis, immune infiltration landscape and drug candidates in pancreatic adenocarcinoma (2026-04-08)
Journal: Discover Oncology (2026) IF: 2.9 -
BET1 serves as a prognostic indicator and promotes cancer proliferation in glioblastoma multiforme (2026-04-29)
-
Integration of a glutamine metabolism-based prognostic signature and a synergistic nanotherapeutic strategy targeting metabolic vulnerabilities in prostate cancer (2026-04-18)
Journal: Discover Oncology (2026) IF: 2.9Products Cited: Fetal Bovine Serum, RPMI-1640 Medium -
Mitochondria-mediated pyroptosis: anti-glioblastoma mechanism of the frankincense-derived compound β-boswellic acid (2026-01-14)
Journal: 3 Biotech (2026) IF: 2.9 -
YARS2 mediates PARPi resistance in pancreatic cancer by regulating the MYC-E2F axis (2026-06-03)
-
DLGAP5-induced glycolysis reprogramming reinforces macrophage M2 polarization to impact BC progression (2026-06-15)
Journal: BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2026) IF: 2.9Products Cited: -
Extracellular vesicles derived from Lactobacillus rhamnosus GG inhibit lung cancer cell invasion and metastasis by regulating ADHFE1 expression to modulate metabolic reprogramming (2026-06-16)
Journal: BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2026) IF: 2.9Products Cited:
